Thalidomide for tocilizumab‐resistant ascites with TAFRO syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thalidomide for tocilizumab‐resistant ascites with TAFRO syndrome

Published:2015-04-22 Issue:6 Volume:3 Page:472-478
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Tatekawa Shotaro¹²,Umemura Koji²,Fukuyama Ryuichi³,Kohno Akio²,Taniwaki Masafumi¹,Kuroda Junya¹,Morishita Yoshihisa²

Affiliation:

1. Division of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan

2. Division of Hematology and Oncology JA Aichi Konan Kosei Hospital Aichi Japan

3. Department of Diagnostic Pathology JA Aichi Konan Kosei Hospital Aichi Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.284

Reference29 articles.

1. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy

2. Castleman's Disease: From Basic Mechanisms to Molecular Therapeutics

3. How I treat HIV-associated multicentric Castleman disease

4. Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

5. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idiopathic multicentric Castleman disease-TAFRO after COVID-19: A case report;Modern Rheumatology Case Reports;2024-08-23

2. Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel;HemaSphere;2023-05-23

3. TAFRO syndrome: A disease that known is half cured;Hematological Oncology;2022-10-03

4. TAFRO syndrome mimicking systemic lupus erythematosus: Case report and literature review;Revista Colombiana de Reumatología (English Edition);2022-10

5. Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: A systematic review;European Journal of Haematology;2022-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3